Around 90% of solid-tumor immunotherapy programs fail - many due to poor target selection. But what if we could eliminate the guesswork?
Instead of relying on predictions, 3T Biosciences are measuring real human T cell responses - using functional screening to find peptide-HLA targets that activate T cells effectively.
Coming up: Cell & Gene Leaders Live, Sun 15 Nov at The Shard · London Life Sciences Week Guide, 15–19 Nov 2026 ·
